NASDAQ:RETA
Reata Pharmaceuticals, Inc.
- Stock
Last Close
172.32
25/09 20:00
Market Cap
6.57B
Beta: 1.53
Volume Today
1.91M
Avg: 1.45M
PE Ratio
−81.11
PFCF: −26.32
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 51.20M - | 51.95M 1.47% | 50.32M 3.15% | 49.86M 0.92% | 48.06M 3.61% | 53.59M 11.51% | 26.52M 50.52% | 9.02M 65.99% | 11.49M 27.40% | 2.22M 80.71% | |
cost of revenue | 124.40M - | ||||||||||
gross profit | 51.20M - | 51.95M 1.47% | 50.32M 3.15% | 49.86M 0.92% | 48.06M 3.61% | 53.59M 11.51% | -97.88M 282.65% | 9.02M 109.21% | 11.49M 27.40% | 2.22M 80.71% | |
selling and marketing expenses | |||||||||||
general and administrative expenses | 13.40M - | 11.51M 14.11% | 13.69M 18.95% | 16.60M 21.25% | 23.26M 40.10% | 32.75M 40.79% | 58.30M 78.02% | 75.13M 28.87% | 99.00M 31.78% | 109.28M 10.38% | |
selling general and administrative expenses | 13.40M - | 11.51M 14.11% | 13.69M 18.95% | 16.60M 21.25% | 23.26M 40.10% | 32.75M 40.79% | 58.30M 78.02% | 75.13M 28.87% | 99.00M 31.78% | 109.28M 10.38% | |
research and development expenses | 45.25M - | 34.30M 24.19% | 35.14M 2.44% | 39.45M 12.27% | 71.27M 80.65% | 97.29M 36.50% | 128.11M 31.68% | 159.08M 24.18% | 155.99M 1.94% | 169.84M 8.88% | |
other expenses | -3K - | 431K 14,466.67% | 932K 116.24% | 1.14M 21.89% | 1.20M 5.90% | 1.13M 6.07% | |||||
cost and expenses | 61.58M - | 48.33M 21.52% | 50.65M 4.81% | 56.74M 12.01% | 94.97M 67.38% | 130.47M 37.38% | 311.74M 138.94% | 235.34M 24.51% | 256.20M 8.86% | 280.25M 9.39% | |
operating expenses | 61.58M - | 48.33M 21.52% | 50.65M 4.81% | 56.74M 12.01% | 94.97M 67.38% | 130.47M 37.38% | 187.34M 43.59% | 235.34M 25.62% | 256.20M 8.86% | 280.25M 9.39% | |
interest expense | 1.45M - | 6.18M 324.76% | 11.20M 81.30% | 36.78M 228.47% | 53.25M 44.79% | 41.77M 21.56% | |||||
ebitda | -7.49M - | 6.09M 181.35% | 1.45M 76.16% | -6.41M 541.43% | -46.48M 624.63% | -76.45M 64.48% | -284.29M 271.88% | -225.19M 20.79% | -243.50M 8.13% | -269.02M 10.48% | |
operating income | -10.42M - | 3.58M 134.38% | -366K 110.22% | -7.10M 1,838.80% | -46.91M 561.15% | -76.88M 63.87% | -285.22M 271.00% | -226.32M 20.65% | -244.71M 8.12% | -270.15M 10.40% | |
depreciation and amortization | 2.93M - | 2.51M 14.18% | 1.82M 27.59% | 682K 62.51% | 437K 35.92% | 431K 1.37% | 932K 116.24% | 1.14M 21.89% | 1.20M 5.90% | 1.13M 6.07% | |
total other income expenses net | 36K - | 43K 19.44% | 32K 25.58% | 214K 568.75% | 698K 226.17% | 2.53M 263.04% | -4.94M 295.03% | -43.91M 788.59% | -53.13M 20.98% | -41.77M 21.38% | |
income before tax | -10.35M - | 3.67M 135.45% | -302K 108.23% | -6.67M 2,107.95% | -47.67M 614.88% | -80.52M 68.92% | -290.16M 260.36% | -270.24M 6.87% | -297.84M 10.21% | -311.93M 4.73% | |
income tax expense | 24.76M - | 2.98M 87.97% | 1.15M 61.46% | -441K 138.41% | 3K 100.68% | 26K 766.67% | 8K 69.23% | -22.49M 281,187.50% | -450K 98.00% | -25K 94.44% | |
net income | -35.10M - | 689K 101.96% | -1.45M 310.45% | -6.23M 329.45% | -47.67M 665.55% | -80.55M 68.96% | -290.17M 260.25% | -247.75M 14.62% | -297.39M 20.03% | -311.90M 4.88% | |
weighted average shs out | 5.50M - | 5.50M 0% | 5.50M 0% | 19.82M 260.30% | 23.93M 20.77% | 27.70M 15.75% | 30.41M 9.79% | 33.71M 10.83% | 36.32M 7.75% | 36.32M 0% | |
weighted average shs out dil | 20.00M - | 20.00M 0% | 5.50M 72.50% | 19.82M 260.30% | 23.93M 20.77% | 27.70M 15.75% | 30.41M 9.79% | 33.71M 10.83% | 36.32M 7.75% | 36.32M 0% | |
eps | -6.38 - | 0.13 102.04% | -0.26 300% | -0.31 19.23% | -1.99 541.94% | -2.91 46.23% | -9.54 227.84% | -7.35 22.96% | -8.19 11.43% | -8.59 4.88% | |
epsdiluted | -1.76 - | 0.03 101.96% | -0.26 853.62% | -0.31 19.23% | -1.99 541.94% | -2.91 46.23% | -9.54 227.84% | -7.35 22.96% | -8.19 11.43% | -8.59 4.88% |
All numbers in USD (except ratios and percentages)